Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors.

Gengenbach, Laura; Graziani, Giulia; Reinhardt, Heike; Rösner, Amelie; Braun, Magdalena; Möller, Mandy-Deborah; Greil, Christine; Wäsch, Ralph; Engelhardt, Monika

Gengenbach, Laura; Graziani, Giulia; Reinhardt, Heike; Rösner, Amelie; Braun, Magdalena; Möller, Mandy-Deborah; Greil, Christine; Wäsch, Ralph; Engelhardt, Monika.

Affiliation

Gengenbach L; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Graziani G; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Reinhardt H; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Rösner A; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Braun M; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Möller MD; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Greil C; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Wäsch R; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Engelhardt M; University Medical Center Freiburg, Department of Hematology, Oncology & Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Cancers (Basel) ; 13(17)2021 Aug 26.

Article de En | MEDLINE | ID: mdl-34503130

Mots clés

frailty; geriatric assessment (GA); immunotherapy; novel agents; relapsed/refractory multiple myeloma (RRMM); revised myeloma comorbidity Index (R-MCI)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Aspects: Patient_preference Langue: En Journal: Cancers (Basel) Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google